Leonabio, Inc. · NASDAQ:LONA
Joseph Edelman reported a 13.90% stake in Leonabio, Inc. (Schedule 13D/A)
Event Dec 18, 2025 · Filed Dec 22, 2025
Joseph Edelman reported a 13.90% stake in Leonabio, Inc., 550,024 shares, with active intent on Dec 18, 2025. Filed Dec 22, 2025 (Schedule 13D/A).
- Stake
- 13.90%
- Shares
- 550,024
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 13.70% | 540,296 |
| Joseph Edelman | 13.90% | 550,024 |
| Perceptive Life Sciences Master Fund, Ltd. | 13.70% | 540,296 |
Source
Related
- Leonabio, Inc.
- Joseph Edelman
- Leonabio, Inc. shareholders
- Schedule 13D/A · Joseph Edelman · Dec 23, 2025
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026